塞力医疗
(603716)
| 流通市值：16.77亿 | | | 总市值：16.77亿 |
| 流通股本：1.91亿 | | | 总股本：1.91亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,420,111,454.42 | 975,687,565.49 | 485,121,921.87 | 2,006,134,334.99 |
| 营业收入 | 1,420,111,454.42 | 975,687,565.49 | 485,121,921.87 | 2,006,134,334.99 |
| 二、营业总成本 | 1,444,210,701.93 | 980,796,893.37 | 465,044,414.73 | 2,070,069,561.38 |
| 营业成本 | 1,137,695,865.9 | 789,547,057.5 | 375,012,633.2 | 1,613,442,473.03 |
| 税金及附加 | 5,425,670.16 | 3,666,139.99 | 1,686,742.01 | 9,779,626.82 |
| 销售费用 | 100,018,355.49 | 60,837,700.23 | 26,892,795.66 | 146,985,940.69 |
| 管理费用 | 122,836,376.29 | 76,861,903.67 | 40,761,042.07 | 183,769,105.24 |
| 研发费用 | 31,457,970.43 | 20,165,973.96 | 9,739,943.89 | 43,211,214 |
| 财务费用 | 46,776,463.66 | 29,718,118.02 | 10,951,257.9 | 72,881,201.6 |
| 其中:利息费用 | 50,580,751.84 | 34,546,906.45 | 13,988,396.49 | 76,187,855.21 |
| 其中:利息收入 | 5,951,084.51 | 5,195,150.25 | 1,982,111.34 | 7,511,945.2 |
| 加:投资收益 | -47,577,734.26 | -1,810,379.62 | -3,391,747.83 | -2,377,861.59 |
| 资产处置收益 | 281,262.2 | 212,832.42 | 48,284.7 | -2,535,164.73 |
| 资产减值损失(新) | -465,161.42 | -358,270.71 | - | -35,517,076.32 |
| 信用减值损失(新) | 19,536,326 | 19,594,697.12 | 321,162.19 | -80,068,123.2 |
| 其他收益 | 2,140,735.08 | 1,897,216.74 | 1,810,158.95 | 4,111,346.55 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -50,183,819.91 | 14,426,768.07 | 18,865,365.15 | -180,322,105.68 |
| 加:营业外收入 | 1,428,624.25 | 188,693.24 | 177,039.1 | 3,013,689.34 |
| 减:营业外支出 | 1,539,192.52 | 1,494,703.49 | 95,068.75 | 15,194,461.37 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -50,294,388.18 | 13,120,757.82 | 18,947,335.5 | -192,502,877.71 |
| 减:所得税费用 | -16,781,741.35 | 4,772,579.22 | 4,610,938.74 | -35,727,722.1 |
| 六、净利润 | -33,512,646.83 | 8,348,178.6 | 14,336,396.76 | -156,775,155.61 |
| 持续经营净利润 | -33,512,646.83 | 8,348,178.6 | 14,336,396.76 | -156,775,155.61 |
| 归属于母公司股东的净利润 | -56,025,062.27 | -4,772,497.51 | 3,156,780.84 | -158,571,532.75 |
| 少数股东损益 | 22,512,415.44 | 13,120,676.11 | 11,179,615.92 | 1,796,377.14 |
| (一)基本每股收益 | -0.28 | -0.02 | 0.02 | -0.82 |
| (二)稀释每股收益 | -0.28 | -0.02 | 0.02 | -0.82 |
| 八、其他综合收益 | -10,669,820.47 | -7,040,616.55 | 48,924.42 | -31,177,834.03 |
| 归属于母公司股东的其他综合收益 | -10,669,820.47 | -7,040,616.55 | 48,924.42 | -31,177,834.03 |
| 九、综合收益总额 | -44,182,467.3 | 1,307,562.05 | 14,385,321.18 | -187,952,989.64 |
| 归属于母公司股东的综合收益总额 | -66,694,882.74 | -11,813,114.06 | 3,205,705.26 | -189,749,366.78 |
| 归属于少数股东的综合收益总额 | 22,512,415.44 | 13,120,676.11 | 11,179,615.92 | 1,796,377.14 |
| 公告日期 | 2024-10-29 | 2024-08-30 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 保留意见 |